Login / Signup

Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.

Jacob I TaylorAshish M KamatMichael A O'DonnellDrupad AnnapureddyJeffrey M HowardWei Shen TanIan M McElreeFacundo DavaroKendrick YimStephen HarringtonElizabeth DyerAnna J BlackPratik KanaburMathieu RoumiguiéSeth LernerPeter C BlackJay D RamanMark A PrestonGary SteinbergWilliam HuangRoger LiVignesh T PackiamSolomon L WolduYair Lotan
Published in: BJU international (2024)
In a selected cohort of patients, initial BST offers comparable survival outcomes to upfront RC in the intermediate term. Rates of recurrence and progression increase over time especially in patients treated with additional lines of BST.
Keyphrases
  • muscle invasive bladder cancer
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • stem cells
  • mesenchymal stem cells
  • patient reported outcomes
  • robot assisted